McCulloch DK , Campbell IW, Wu FC et al. The prevalence of diabetic impotence . Diabetologia1980;18:279-83.
2.
Feldman HA, Goldstein I., Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol1994;151:54-61.
3.
Sullivan ME, Keoghane SR, Miller MAW.Vascular risk factors and erectile dysfunction. Br J Urol2001;87:838-45.
4.
Shabsigh R., Fishman IJ, Schum C. et al. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology1991;38:227-31.
5.
Bulpitt CJ, Dollery CT, Carne S.Change in symptoms of hypertensive patients after referral to hospital clinic . Br Heart J1976;38:121-8.
6.
Bansal S.Sexual function in hypertensive men. A critical review of the literature . Hypertension1988;12:1-10.
7.
Green AWSexual activity and the postmyocardial infarction patient. Am Heart J1975;89:246-52.
8.
De Berardis G., Franciosi M., Belfiglio M. et al. Erectile dysfunction and quality of life in type 2 diabetic patients. A serious problem too often overlooked. Diab Care2002;25:284-91.
9.
Paige NM, Hays RD, Litwin MS et al. Improvement in well being and relationships of users of sildenafil . J Urol2001;166:1774-8.
10.
Prisant LM, Carr AA, Bottini PB et al. Sexual dysfunction with antihypertensive drugs. Arch Int Med1994;154:730-6.
11.
Grimm RH, Grandits GA, Prineas RJ et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment Of Mild Hypertension Study (TOMHS). Hypertension1997;29:8-14.
12.
Price D., O'Malley BP, James MA et al. Why are impotent diabetic men not being treated?Prac Diab Int1991;8:10-11.
13.
Cummings MH , Meeking D., Warburton F. et al. The diabetic male's perception of erectile dysfunction. Prac Diab Int1997;14:100-02.
14.
Price DESildenafil citrate (Viagra) efficacy in the treatment of erectile dysfunction in patients with common concomitant conditions. Int J Clin Prac1999;102(suppl):21-3.
15.
Pryor J.Vardenafil: Update on clinical experience. Int J Impot Res2002; 14(suppl 1): S65-S69.
16.
Porst H.IC351 (tadalafil, Cialis): Update on clinical experience. Int J Impot Res2002;14(suppl 1):S57-S64.
17.
Jackson G., Betteridge J., Dean J. et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Prac1999;53:445-51.
18.
Cheitlin MD , Hunter AM Jr, Brindis RG et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation1999 ;99:168-77.
19.
Hellerstein HK, Friedman EHSexual activity and the postcoronary patient . Arch Int Med1970;125:978-90.
20.
Muller JE, Mittelman A., Maclure M. et al. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. JAMA1996;275:1405-9.
21.
The IONA Study Group.Effect Of nicorandil on coronary events in patients with stable angina: The Impact Of Nicorandil in Angina (IONA) randomized trial. Lancet2002;359:1269-75.
22.
von Keitz, Stroberg P, Bukofzer S. et al. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction . BJU Int2002;89:409-15.
